|
Index of reports
> Cases resulting in hospitalization (66)
> Cases with Pulmonary Alveolar Haemorrhage (8)
Below is the selection of adverse event reports related to Tenormin (Atenolol) that includes cases resulting in hospitalization where reactions include pulmonary alveolar haemorrhage.
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-06-20
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-06-18
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-05-23
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-01-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon
Adverse event in male receiving Tenormin (Atenolol)
Reported by a physician from Japan on 2007-04-26
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-01-15
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-15
Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-03-27
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-02-22
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-02-22
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
Adverse event in male receiving Tenormin (Atenolol)
Reported by a pharmacist from Japan on 2007-02-08
Patient: male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2006-11-03
Other drugs received by patient: Norvasc
|
